Singapore, Oct. 3 -- Japanese pharmaceutical firm Daiichi Sankyo has established Daiichi Sankyo Research Institute in San Diego, US representing the third research institute established outside of the company's flagship research centre in Japan since the opening of locations in Boston and Munich in 2024.

"Establishing a dedicated scientific presence in San Diego marks a significant milestone for Daiichi Sankyo as we continue to deepen our long-standing relationships in one of the world's leading innovation hubs and expand our global research strategy," said Yuki Abe, PhD, Head of R&D Division in Japan and Head of Research, Daiichi Sankyo. "We look forward to further strengthening our research collaborations by embedding our scientists in...